These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17301725)

  • 1. Transient chorea in a patient with type 1 diabetes may induce a reduction in insulin demand through increased spontaneous movements.
    Cadario F; Moreno G; Esposito S; Peruzzi C; Bona G
    Minerva Pediatr; 2007 Feb; 59(1):49-52. PubMed ID: 17301725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes.
    Toledo FG; Menshikova EV; Ritov VB; Azuma K; Radikova Z; DeLany J; Kelley DE
    Diabetes; 2007 Aug; 56(8):2142-7. PubMed ID: 17536063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle.
    Corpeleijn E; Saris WH; Blaak EE
    Obes Rev; 2009 Mar; 10(2):178-93. PubMed ID: 19207879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
    Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term physical training increases liver IGF-I in diabetic rats.
    Leme JA; Silveira RF; Gomes RJ; Moura RF; Sibuya CA; Mello MA; Luciano E
    Growth Horm IGF Res; 2009 Jun; 19(3):262-6. PubMed ID: 19201234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How hypoglycaemia can affect the life of a person with diabetes.
    Frier BM
    Diabetes Metab Res Rev; 2008 Feb; 24(2):87-92. PubMed ID: 18088077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education.
    Wild D; von Maltzahn R; Brohan E; Christensen T; Clauson P; Gonder-Frederick L
    Patient Educ Couns; 2007 Sep; 68(1):10-5. PubMed ID: 17582726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of new technologies in treating children and adolescents with type 1 diabetes mellitus.
    Shalitin S; Phillip M
    Pediatr Diabetes; 2007 Oct; 8 Suppl 6():72-9. PubMed ID: 17727388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin binding to antibodies is a risk factor for inexplicable severe hypoglycaemia in children with type-1 diabetes mellitus.
    Seewi O; Jaeger C; Bretzel RG; Schönau E
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):293-7. PubMed ID: 18484562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content.
    Toledo FG; Menshikova EV; Azuma K; Radiková Z; Kelley CA; Ritov VB; Kelley DE
    Diabetes; 2008 Apr; 57(4):987-94. PubMed ID: 18252894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.